FASL Antikörper (AA 103-281) (FITC)
Kurzübersicht für FASL Antikörper (AA 103-281) (FITC) (ABIN2601386)
Target
Alle FASL Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 103-281
-
Spezifität
- Human FASLG / FASL / Fas Ligand
-
Aufreinigung
- Affinity purified
-
Immunogen
-
Recombinant FASL (Gln103-Leu281) expressed in E. coli.
Type of Immunogen: Recombinant protein -
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Approved: WB
Usage: The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested. -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- PBS, pH 7.4, 0.02 % sodium azide, 50 % glycerol.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C,-80 °C
-
Informationen zur Lagerung
- Store frozen product at or below -20°C. Thawed product may be stored for 2-4 weeks at 4°C. For optimal storage, aliquot to smaller portions and store at -20°C to -70°C. Avoid freeze-thaw cycles.
-
-
- FASL (Fas Ligand (TNF Superfamily, Member 6) (FASL))
-
Andere Bezeichnung
- FASLG / Fas Ligand
-
Hintergrund
-
Name/Gene ID: FASLG
Family: TNF
Synonyms: FASLG, ALPS1B, Apoptosis antigen ligand, APTL, CD95L, CD95 ligand, CD178 antigen, CD95-L, Fas antigen ligand, Fas ligand, FASL, TNFSF6, APT1LG1, CD178 -
Gen-ID
- 356
-
Pathways
- Apoptose, EGFR Signaling Pathway, Production of Molecular Mediator of Immune Response, Positive Regulation of Endopeptidase Activity
Target
-